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 Abstract 
Diaphragmatic fatigue is known to limit endurance performance during heavy 
exercise in humans.  Previous reports have shown that diaphragmatic fatigue is reduced 
in rats with N-acetylcysteine (NAC; a nonspecific antioxidant) infusion, suggesting that 
oxidative stress contributes to this fatigue.  However, it is not known if oral 
supplementation of NAC will reduce respiratory muscle fatigue during heavy exercise in 
humans.    Therefore, the purpose of this study was to determine the effect of an acute 
oral dose of NAC on respiratory muscle fatigue during whole body heavy exercise.  Eight 
healthy, non-smoking men (22+2 yrs), with no history of cardiovascular or lung disease, 
completed baseline pulmonary function tests followed by an incremental cycle VO2peak 
test.  A randomized, double blind crossover design was then used where subjects were 
given either placebo (PLA) or NAC (1800 mg) 45 min prior to a 30 minute constant load 
(85% VO2peak) discontinuous (six-five minute stages) or continuous (cycle until volitional 
exhaustion) exercise test.  Tests were separated by approximately one week.  Maximum 
pressures (inspiratory, PImax; expiratory, PEmax) and venous blood samples (plasma lactate 
and total plasma glutathione) were made prior to- and following each 5-min of exercise in 
discontinuous tests and pre- and post-exercise in continuous tests.  Subject’s VO2peak was 
43+5 ml/kg/min.  There was no difference (p>0.05) in PImax between NAC (127.9+34.1 
cmH2O) or PLA (134.1+28.1 cmH2O) at rest.  During exercise, PImax was significantly 
lower (~14%) in 6 of 8 subjects with PLA compared to NAC at minutes 25 and 30 of the 
discontinuous test indicating respiratory muscle fatigue.  With NAC, PImax did not change 
 
(p>0.05) from rest throughout exercise indicating no respiratory muscle fatigue.  There 
was no difference (p>0.05) in PEmax, plasma glutathione, lactate, oxygen uptake (VO2), 
ventilation (VE), heart rate (HR), or rating of perceived exertion between PLA and NAC 
at rest or during exercise.  Time to exhaustion was not different (p>0.05) during the 
continuous tests (PLA: 1263 + 334 sec; NAC: 1047 + 136 sec).  These results suggest 
that an acute dose of NAC reduces respiratory muscle fatigue during high intensity 
exercise but does not alter other ventilatory or metabolic indices.   The significance of 
this reduced respiratory muscle fatigue with NAC on whole body exercise performance 
remains to be determined. 
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CHAPTER 1 - Introduction 
The pulmonary system has been shown to limit exercise performance in some 
healthy subjects.  Specifically, at high intensity exercise (>80%VO2peak), respiratory 
muscles have been shown to fatigue (Johnson, Saupe, & Dempsey, 1992).  This 
respiratory muscle fatigue has been hypothesized to be a primary determinant in 
pulmonary performance, as well as exercise performance (Dempsey, Romer, Rodman, 
Miller, & Smith, 2006).  Respiratory muscle fatigue has been shown to be associated with 
hydrogen ion production, glycogen depletion, and, recently, the production of reactive 
oxygen species (ROS) within the respiratory and locomotor muscles (Barreiro et al., 
2006; Davies, Quintanilha, Brooks, & Packer, 1982; Juel, 2006; Kerksick & Willoughby, 
2005; McKenna et al., 2006; Medved et al., 2004b; Medved, Brown, Bjorksten, & 
McKenna, 2004a; Reid, Stokic, Koch, Khawli, & Leis, 1994; Reid, 2001a; Supinski, 
1998).  At the cellular level, ROS can alter chemical balances, blood flow, damage cell 
membranes, and cause DNA morphing (Davies et al., 1982; Kerksick & Willoughby, 
2005; Medved et al., 2004a).  ROS are produced in fatiguing muscle and free radical 
scavengers/antioxidants are needed to combat ROS and prevent cellular damage and 
maintain homeostasis.   
N-acetylcysteine (NAC) is a free radical scavenger that has been associated with 
decreased levels of fatigue in limb muscles (Barreiro et al., 2006; Kerksick & 
Willoughby, 2005; McKenna et al., 2006; Medved et al., 2004b; Sen & Packer, 2000; 
Shindoh, DiMarco, Thomas, Manubay, & Supinski, 1990) and, more recently in the 
respiratory muscles (Sen & Packer, 2000; Shindoh et al., 1990; Supinski, Stofan, Ciufo, 
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& DiMarco, 1997b; Travaline et al., 1997).  Glutathione (GSH), an endogenous 
antioxidant, is oxidized in a naturally occurring cellular process (Sen & Packer, 2000; 
Sjodin, Hellsten Westing, & Apple, 1990; Smith & Reid, 2006), but when it is produced 
it increases the number of ROS (Sen & Packer, 2000; Sjodin et al., 1990; Smith & Reid, 
2006).  When NAC is present in the cell, it dissociates into cysteine and aids in the 
process of returning oxidized glutathione (GSSG) back into GSH in a process called GSH 
biosynthesis (Sen, Rankinen, Vaisanen, & Rauramaa, 1994b; Sen & Packer, 2000; Sjodin 
et al., 1990; Smith & Reid, 2006).  This same process allows GSH to combine with 
hydrogen peroxide, a ROS, to form water (Sen & Packer, 2000; Sjodin et al., 1990; Smith 
& Reid, 2006) neutralizing the cellular environment.   
NAC supplementation has been shown in several studies, primarily animals, to 
reduce respiratory muscle fatigue (Barreiro et al., 2006; Kerksick & Willoughby, 2005; 
McKenna et al., 2006; Medved et al., 2004b; Shindoh et al., 1990).  However, the 
mechanism of how NAC delays this fatigue has not been examined (Juel, 2006; 
McKenna et al., 2006; Medved et al., 2003; Medved et al, 2004a; Mishima, Yamada, 
Matsunaga, & Wada, 2005; Sen & Packer, 2000; Shindoh et al., 1990).  It is presently 
unknown whether an acute oral doses of NAC will reduce respiratory muscle fatigue 
and/or improve exercise performance in humans.   
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CHAPTER 2 - Review of Literature 
High intensity exercise (>85%VO2max) has been shown to cause respiratory 
muscle fatigue (Babcock, Pegelow, Harms, & Dempsey, 2002; Dempsey et al., 2006; 
Johnson, Babcock, Suman, & Dempsey, 1993; Ozkaplan, Rhodes, Sheel, & Taunton, 
2005) which has been reported to limit exercise tolerance (Dempsey et al., 2006).  
Therefore, it is of interest to identify factors which either contribute to this fatigue, or 
help alleviate it.  Reactive oxygen species (ROS) have been identified in promoting 
respiratory muscle fatigue.  Antioxidants may therefore, be useful to combat ROS and 
potentially reduce respiratory muscle fatigue.  Infusion of one specific antioxidant, N-
Acetylcysteine (NAC), has been shown to decrease respiratory muscle fatigue and 
increase whole body exercise performance (Koechlin et al., 2004; Reid et al., 1994).  It is 
not known if an acute oral dose will show similar effects.  This review will first examine 
respiratory muscles during exercise, followed by the role of ROS on skeletal muscle 
fatigue, and finally, the role of antioxidants, specifically NAC, on respiratory muscle 
performance. 
 
Respiratory Muscles during Exercise 
The primary respiratory muscle is the diaphragm, while the internal and external 
intercostals, sternocleidomastoids, and abdominals serve accessory roles.  The diaphragm 
tends to resist fatigue due to its high oxidative capacity and increased amount of blood 
flow during exercise (Dempsey et al., 2006).  As exercise intensity exceeds 80% VO2peak, 
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the diaphragm reportedly fatigues, as shown by bilateral phrenic nerve stimulation 
(Johnson et al., 1993), and accessory muscles are recruited to help maintain ventilation 
(Babcock et al., 2002; Dempsey et al., 2006; Johnson et al., 1993; Ozkaplan et al., 2005).  
This respiratory muscle fatigue seen with high intensity exercise may limit whole body 
exercise performance by decreasing vascular conductance and blood flow to the 
locomotor limb musculature (Babcock et al., 2002; Harms et al., 1997; Harms et al., 
1998) and increasing work of breathing (Romer, Lovering, Haverkamp, Pegelow, & 
Dempsey, 2006; Sheel et al., 2001). 
 
Significance of Respiratory Muscles during Exercise 
Respiratory Muscles and Work of Breathing 
At rest, the amount of oxygen needed (the cost of breathing) is negligible 
compared to what is needed during exercise.  In fact, Aaron, Seow, Johnson, and 
Dempsey. (1992) reported that approximately 2% of total body VO2 (6-10 ml/min) is 
required to sustain ventilation.  As ventilation increases during voluntary hyperpnea, the 
cost or work of breathing, and thus the cost of oxygen has been shown to increase as well 
(Coast & Krause, 1993; Shephard, 1966).  Therefore, as the body transitions from rest to 
moderate exercise, the work of breathing is increased from 2% to 3-5% and 10-15% 
(300-600 ml/min) of total body VO2 in sedentary and highly fit individuals, respectively 
(Aaron et al., 1992).  This increase in work of breathing is accompanied by changes in 
metabolic effects, such as an increase in cardiac output; however, these changes are 
usually seen during heavy exercise (Aaron et al., 1992; Harms et al., 1998). 
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Respiratory Muscles, Exercise, and Blood Flow 
Respiratory muscle fatigue during exercise leads to cardiovascular adjustments.  
In particular, during whole body exercise, there is a “competition” between respiratory 
muscles and locomotor muscles for the available cardiac output such that respiratory 
muscles apparently “steal” blood flow and oxygen from locomotor muscles (Harms et al., 
1997).  Although this “competition” has not been measured directly in the human model, 
radioactive microspheres and flow probes have been utilized in the animal model to 
determine changes in blood flow during exercise (Musch et al., 1987; Poole et al., 2000).  
During incremental treadmill running, the mongrel dog showed an increase in blood flow 
(~16-25%) to the respiratory muscles (Musch et al., 1987).  Similarly, Poole et al. (2000) 
showed an increase in blood flow (~260%) to the rat diaphragm during maximal exercise 
when compared to resting values.  These authors also reported that accessory respiratory 
muscles, such as the intercostals, scalenus, and abdominals, also show an increase in 
blood flow of 6- to 10-fold (68 + 6, 152 + 36, and 148 + 21 ml/min/100g, respectively).  
Vascular conductance also increased in these accessory muscles suggesting the necessity 
to increase blood flow to the respiratory muscles due to increased hyperpnea and the high 
oxidative capacity of the diaphragm (Poole et al., 2000). 
Although a shift in blood flow between vascular beds during exercise has not 
been directly measured in humans, cardiac output to the respiratory muscles has been 
previously determined by use of a Swann-Ganz catheter and the direct Fick method for 
measuring cardiac output.  Harms et al. (1998) found that approximately 14-16% of total 
cardiac output is directed to the respiratory muscles during maximal exercise.  The 
cardiac output in this case is limited to the working locomotor musculature, and the 
exercising limbs and respiratory muscles must therefore compete for the available blood 
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flow.  Thus, the exercising limbs may be affected by the blood flow competition between 
the respiratory muscles and the locomotor muscles.  Local reflexes, leading to 
sympathetic vasoconstriction, are the likely mechanism for this effect (Harms et al., 
1997; St Croix, Morgan, Wetter, & Dempsey, 2000).   
Respiratory muscle fatigue is thought to contribute to increasing ventilatory 
requirements and influence exercise performance by reducing locomotor muscle blood 
flow and oxygen transport, leading to whole body fatigue (Dempsey et al., 2006; Harms, 
Wetter, St Croix, Pegelow, & Dempsey, 2000).  The effect of respiratory muscle fatigue 
on exercise performance was further demonstrated by McConnell and Lomax (2006).  
These authors reported that during inspiratory muscle fatigue and plantar flexion 
exercise, left ventricular contraction decreased, indicating that inspiratory muscle work 
increases with skeletal muscle fatigue (McConnell & Lomax, 2006).  This data supports 
the blood flow steal phenomenon.  Others have shown a decrease in limb blood flow and 
an increase in limb vascular resistance during inspiratory muscle fatigue (Sheel et al., 
2001).  These authors found that cardiovascular adjustments are limiting exercise 
performance due to increasing resting limb blood flow during respiratory muscle fatigue 
(Sheel et al., 2001).  However, the mechanism for blood flow distribution is likely, 
though not proven, to be an activated metaboreflex (type III and IV afferents) which is 
linked to respiratory muscle fatigue (Dempsey et al., 2006; Sheel et al., 2001; St Croix et 
al., 2000).   
Respiratory Muscles and Exercise Performance 
Decreasing the work of breathing during heavy exercise has been shown to 
improve whole body exercise performance (Harms et al., 2000; Romer et al., 2006).  
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During high-intensity cycling, exercise time to fatigue is inversely related to the level of 
prevailing inspiratory muscle work.  Thus, as respiratory muscle fatigue is reduced, 
exercise time increases, suggesting that inspiratory muscle fatigue limits limb 
performance (McConnell & Lomax, 2006).  Moreover, Romer et al. (2006) have shown 
increases in peripheral muscle fatigue during incremental cycling exercise with 
proportional assist ventilator (loaded breathing to increase the work of breathing).  These 
authors have suggested when fatigue of the respiratory muscles is enhanced by increasing 
the work of breathing, the peripheral muscles, the quadriceps in this case, fatigue much 
quicker (Romer et al., 2006).   
Another strategy to reduce respiratory muscle work and enhance exercise 
performance is to increase respiratory muscle strength by inspiratory muscle training.  
Downey et al. (2007) showed that inspiratory muscle training increased diaphragm 
thickness (8-12%), increased respiratory muscle strength (25%), and decreased 
respiratory muscle fatigue by ~7.5% during exercise at 80% VO2max.  In agreement, 
Verges et al. (2007) found that respiratory muscle fatigue was reduced >10% with 
respiratory muscle training.  However, neither of these investigators saw a change in 
cycling endurance exercise, implying a change in respiratory muscle fatigue, via 
respiratory muscle training, does not necessarily influence whole body exercise 
performance (Downey et al., 2007; Verges, Lenherr, Haner, Schulz, & Spengler, 2007).  
Therefore, the effect of reducing respiratory muscle fatigue on whole body exercise 
performance is not clear.   
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Reactive Oxygen Species Increase Fatigue 
Reactive oxygen species are oxidized molecules (molecules with an unpaired 
electron) which react with reduced molecules (molecules with all paired electrons).  This 
transfer of electrons or hydrogen ions from one molecule to the other is called oxidation-
reduction reactions.  The over consumption of oxygen, leading to the production of 
reactive oxygen species, results from: 1) an error in a mitochondrial oxidative process, 2) 
a hypoxic environment inside the capillary endothelium (i.e. exercise and disease states), 
and/or 3) muscle and tissue damage from an oxidative burst from inflammatory cells 
(Sjodin et al., 1990) (i.e. prolonged intense exercise or eccentric-based exercise states 
(Kerksick & Willoughby, 2005)).  Reactive oxygen species (ROS) have been suggested 
to increase fatigue (Juel, 2006) and impair contracting skeletal muscle (Davies et al., 
1982; Reid et al., 1992).  Although moderate exposure of ROS to the musculature 
increases their ability to generate force, excessive ROS production can significantly 
reduce muscle force generation (Shindoh et al., 1990).  With regards to exercise, levels of 
ROS also increase; therefore, ROS levels may have a significant contribution to exercise 
performance (Juel, 2006) and, more specifically, muscle fatigue (Davies et al., 1982; 
Reid et al., 1992).   
 
Antioxidants 
Antioxidants work in the body as reducing agents and are oxidized when ROS 
“steal” a paired electron.  The purpose of antioxidants is to produce water and a stable 
molecule.  The body’s endogenous antioxidant system (antioxidants that originate in the 
body) is unable to remove excess ROS if there are not enough antioxidants (molecules 
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capable of slowing or preventing oxidation-reduction reactions).  These conditions occur 
if there is: 1) inadequate antioxidant content in the normal diet, 2) a high intake of pro-
oxidants, 3) exposure to chemicals or ultraviolet light, 4) injury, and/or 5) intense 
exercise (Kerksick & Willoughby, 2005).  The production of ROS augments muscle 
fatigue in the rat (Reid et al., 1992) and canine diaphragm (Nashawati, Dimarco, & 
Supinski, 1993; G. Supinski, Nethery, Stofan, & DiMarco, 1997) and the skeletal muscle 
of the mouse (Barclay & Hansel, 1991).  Therefore, enhancing exogenous antioxidant 
intake (the antioxidants that are taken in as food, supplements, or vitamins) may have a 
favorable effect on muscle performance.   
 
Antioxidants Decrease Fatigue 
Increasing certain antioxidants (i.e. glutathione, n-acetylcysteine, ά-lipoid acid, 
and vitamins A, E, and C) in the body’s circulation will prevent the accumulation of ROS 
thereby reducing oxidative stress (Kerksick & Willoughby, 2005; Matuszczak et al., 
2005; Medved, Brown, Bjorksten, & McKenna, 2004).  [Oxidative stress indices are 
exceeded due to the ROS increased levels in the cytosol (Reid et al., 1992), extracellular 
space (Reid, Shoji, Moody, & Entman, 1992), and vascular compartment (Kolbeck, She, 
Callahan, & Nosek, 1997; O'Neill, Stebbins, Bonigut, Halliwell, & Longhurst, 1996).  
Oxidative stress also elevates glutathione oxidation (Mishima et al., 2005) and 
malondialdehyde (Reid, 2001b).]  The use of antioxidant compounds has aided in the 
reduction of fatigue in numerous preparations such as canine diaphragm (G. Supinski et 
al., 1997) and gastrocnemius muscle (Barclay & Hansel, 1991), rat diaphragm bundles 
(Reid et al., 1992), and human diaphragm (Travaline et al., 1997).  They have also shown 
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to reduce fatigue in voluntary exercise in mice (Novelli, Falsini, & Bracciotti, 1991), 
humans (Lands, Grey, & Smountas, 1999), and human limb electrical stimulation (Reid 
et al., 1994).  Subsequently, maintaining pre-fatigue levels of oxidation-reduction 
sensitive functions and oxidative stress is the potential outcome when using supplemental 
antioxidants (Reid et al., 1994). 
 
N-Acetylcysteine 
One specific antioxidant which has been suggested to decrease respiratory muscle 
fatigue is N-Acetylcysteine (NAC).  This antioxidant is a ROS scavenger (Aruoma, 
Halliwell, Hoey, & Butler, 1989), that maintains glutathione status in muscle cells 
(Kerksick & Willoughby, 2005), and has been shown to decrease exercise-induced 
oxidative stress (Koechlin et al., 2004).  NAC, a reduced cysteine donor, acts in the cell 
supporting glutathione (GSH) synthesis and resynthesis and opposing oxidative stress 
(Ruffmann & Wendel, 1991).  NAC works in the cell by scavenging superoxide anion 
radicals, hydroxyl radicals, and H2O2.  It also supplies cysteine for de novo synthesis of 
GSH (Shindoh et al., 1990).  Meister (1998) has shown that GSH is used in the body by 
GSH peroxidases.  GSH peroxidases are known to reduce H2O2 and organic peroxides 
and form GSSG (oxidized glutathione).  They also protect the cell proteins and cell 
membranes against oxidation (Meister, 1988).  NAC is an acetylated version of cysteine, 
which is the rate limiting substrate for glutathione synthesis in the body (Sen, 2001).  
Supplementation of NAC has also been shown to modify vascular tone and redistribute 
cardiac output, which may have an effect on respiratory and skeletal muscle fatigue 
(Harrison, Wendon, Gimson, Alexander, & Williams, 1991). 
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N-Acetylcysteine and Skeletal Muscle Fatigue 
Muscle fatigue in humans is associated with oxidative stress and an increase in 
ROS production.  To reduce the impact of ROS, Reid et al. (1994) discovered that 
pretreatment with NAC is useful for reducing the amount of human skeletal muscle 
fatigue.  This finding was established using intravenous loading (150mg/kg) and 
repetitive, low-frequency electrical stimulation (10Hz) in the tibialis anterior.  NAC 
increased force production compared to placebo conditions, starting at minute three and 
continued until trials concluded.  However, using the same protocol, with high-frequency 
stimulation (40 Hz), NAC was not significantly different than placebo conditions.  
Therefore, this landmark study influenced others to use pretreatment of NAC during 
whole body exercise (McKenna et al., 2006; Medved et al., 2003) and voluntary muscle 
contraction (Koechlin et al., 2004).  Medved et al. (2003) used intravenous NAC 
(125mg/kg/h for 15 minutes and 25mg/kg/h during testing session) during high-intensity 
(130% VO2peak) intermittent cycling in healthy humans.  These authors found that NAC 
altered blood redox status and impaired plasma potassium (K+) regulation, but did not 
enhance performance during the high-intensity intermittent cycling exercise.  Although 
these authors did not see an improvement in exercise performance, McKenna et al. 
(2006) did see an improvement of ~24% during submaximal cycling exercise in healthy 
men.  In a different human population, Koechlin et al. (2004) used chronic oral dosing 
(600mg 3xday with an additional 600mg on testing day) in chronic obstructive 
pulmonary disease patients.  These authors found that NAC prevented exercise-induced 
oxidative stress and enhanced quadriceps endurance by 25%.  To date, results are 
controversial and the effect of NAC on the respiratory muscles has not been sufficiently 
established.  
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N-Acetylcysteine and Respiratory Muscle Fatigue 
During strenuous exercise, contractions in the diaphragm and other respiratory 
muscles release ROS (Shindoh et al., 1990; Supinski et al., 1997a; Supinski et al., 1997b) 
and it is possible that ROS may contribute to fatigue (Reid et al., 1992b).  Due to NAC’s 
ability to increase GSH levels, it is possible for NAC to establish a more cellular 
favorable environment (a balance between antioxidants and ROS), therefore improving 
exercise performance (Kerksick & Willoughby, 2005).  Low-frequency diaphragmatic 
fatigue has been attributed to an increased amount of ROS (Reid et al., 1992b; Supinski 
et al., 1997b), but NAC has also been shown to attenuate this fatigue during low-
frequency diaphragmatic electrical stimulation (Barclay & Hansel, 1991; Hida et al., 
1996; Nashawati et al., 1993; Reid et al., 1994; Shindoh et al., 1990; Travaline et al., 
1997).  To date, the majority of studies have utilized infusion of NAC to determine its 
effect on respiratory muscle fatigue. 
Intravenous loading has been found to be effective in decreasing respiratory 
muscle fatigue (Shindoh et al., 1990; Supinski et al., 1997a; Travaline et al., 1997), 
decreasing skeletal muscle fatigue (Matuszczak et al., 2005; Reid et al., 1994), changing 
muscle GSH levels (Matuszczak et al., 2005; Medved et al., 2003; Supinski et al., 1997a), 
and affect exercise performance (Medved et al., 2004b; Reid et al., 1994; Travaline et al., 
1997).  A study by Supinski et al. (1997b) determined that rats infused with NAC 
(150mg/kg) were able to tolerate and maintain higher inspiratory pressure, and sustain 
higher inspired volumes.  These authors also demonstrated that rats infused with NAC 
were able to tolerate greater inspiratory pressures and volumes prior to respiratory arrest 
development and that diaphragmatic GSH levels were significantly reduced compared to 
unloaded controls (Supinski et al., 1997).  In the rabbit diaphragm strip, Shindoh et al. 
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(1990) found similar results to that of Supinski et al. (1997b).  Intravenous NAC 
decreased fatigue compared to control groups during rhythmic, repetitive isometric 
contraction (Shindoh et al., 1990).  The force-frequency relationship also decreased with 
placebo.  In addition to these animal models, Travaline et al. (1997) demonstrated, in 
healthy human subjects, that increased inspiratory resistive loading and task endurance 
were greater after NAC administration (150mg/kg).  This study utilized 
transdiaphragmatic twitch occlusion to initiate diaphragmatic fatigue.  These authors also 
found that high-frequency diaphragmatic fatigue had less of an effect with NAC than the 
low-frequency diaphragmatic fatigue effect with NAC.  These results are likely due to 
improvements in both diaphragm strength and endurance as well as ROS mediated effects 
by NAC treatment.   
To date, there have been few studies examining the effects of oral 
supplementation of NAC on skeletal muscle fatigue.  Some reports suggest that oral 
supplementation seems to have similar effects as intravenous loading.  In dogs, oxidative 
stress was reduced by oral supplementation of NAC (3mmol/kg every 24 hours) during 
high intensity respiratory loading (Barreiro et al., 2006).  Oxidative stress was also 
reduced in chronic obstructive pulmonary disease (COPD) patients who supplemented 
with oral NAC (3x200mg-three times per day for four days with an additional 600mg on 
test day) (Koechlin et al., 2004).  This increased the dynamic one-repetition maximum 
leg extension by 40% and increased endurance by 25%.  Another study using a human 
model showed no change in blood GSH with NAC dosing (4x200mg per day for two 
days with an additional 800mg on test day) (Sen, Atalay, & Hanninen, 1994).  However, 
this study tested the difference on blood and plasma levels of GSH and GSSG with 
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differing exercise intensities.  Although these studies have shown a decrease in oxidative 
stress with chronic oral supplementation in animal and human models and an increase in 
endurance and strength performance, it is still not known if an acute oral dose will have 
similar results.   
 
Summary 
Respiratory muscles fatigue during high-intensity exercise.  With the onset of 
respiratory muscle fatigue, cardiac output may redistribute from the limbs to the 
respiratory muscles compromising locomotor blood flow and adversely affecting 
performance.  Reactive oxygen species have been implicated to contribute to respiratory 
muscle fatigue.  N-Acetylcysteine may reduce reactive oxygen species in respiratory 
muscles and potentially negate respiratory muscle fatigue.  To date, decreased respiratory 
muscle fatigue in humans using an acute oral dose of NAC has never been determined. 
 
Statement of the Problem 
The purpose of the study is to determine the effects of an acute oral dose of N-
Acetylcysteine on respiratory muscle fatigue in healthy, active college-aged males during 
heavy exercise. 
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Hypotheses 
We hypothesized that, compared to placebo based control trials, acute NAC 
supplementation prior to 30 minutes of heavy, constant-load exercise, will increase 
plasma glutathione levels and decrease respiratory muscle fatigue. 
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 CHAPTER 3 - Methods 
 Nine healthy men were recruited to participate in this study.  All were free from 
pulmonary and heart disease as determined from medical history questionnaire.  The 
subjects were active, but not competitively trained, and maintained their normal activity 
status throughout testing.  Each participant was told not to consume alcohol or participate 
in vigorous activity during 24 hours prior to testing, not to consume antioxidants, 
vitamins, or supplementations of any kind throughout testing, and not to consume food 
within two hours prior to testing.  Informed consent was obtained from each subject and 
all procedures were approved by the Kansas State University Human Research Board, 
Manhattan, KS. 
 
Experimental Design 
Pulmonary function tests (PFT) include total lung capacity (TLC), inspiratory and 
expiratory pressures (PImax and PEmax, respectively), and maximum flow-volume loops 
(MFVL) were determined during the first testing session.  A peak oxygen uptake 
(VO2peak) test on an electromagnetically braked cycle ergometer (800 Ergometer, 
SensorMedics, USA) was then performed by each subject.  Seat height was measured and 
used for all future tests and toe clips were in place for every exercise test on the cycle 
ergometer.  After VO2peak was established, 2-4 practice sessions took place within one 
week to determine a workload that elicited ~85% VO2peak and to familiarize the subjects 
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with all equipment.  After all submax tests were complete, one participant dropped out 
for personal reasons leaving eight subjects for data analysis. 
Following the practice sessions, a randomized, double blind cross-over study was 
used.  Subjects were initially randomly assigned to either two discontinuous or two 
continuous protocols.  After the first protocol was complete, the subject completed the 
alternative protocol for a total of four testing sessions.  Each protocol consisted of either a 
placebo (PLA: cornstarch) or experimental (NAC: N-Acetylcysteine) trial in random 
order.  A dosage of 1800mg (3x600mg) of NAC was used during the loading sessions 
based on the study by Koechlin et al. (2004), who showed significant decreases in 
oxidative fatigue in the human quadriceps using this level of oral dosing.  PLA were in 
identical pill casings as NAC (3 pills).  A senior investigator remained un-blinded 
throughout the study, and administered the supplements. 
 
Pulmonary Function Tests 
Total lung capacity (TLC) and residual volume (RV) were measured using a 
nitrogen washout technique.  Maximal inspiratory pressure (PImax) was measured from 
RV and maximal expiratory pressure (PEmax) was measured from TLC.  PImax and PEmax 
are measurements of respiratory muscle strength measured at the mouth and have been 
shown to be a good estimate of respiratory muscle strength (Huang, Martin, & 
Davenport, 2003; Inbar, Weiner, Azgad, Rotstein, & Weinstein, 2000; Romer, 
McConnell, & Jones, 2002a; Romer, McConnell, & Jones, 2002b; Sonetti, Wetter, 
Pegelow, & Dempsey, 2001).  All PFT measurements were performed in triplicate except 
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during the discontinuous bouts when PImax and PEmax were measured in duplicate due to 
time constraints.  The average values of acceptable trials were used in analysis. 
 
Peak Oxygen Uptake (VO2peak) 
An incremental exercise cycle ergometer (800 Ergometer, SensorMedics, USA) 
test to exhaustion was performed to determine VO2peak on a breath by breath basis using a 
metabolic cart (Vmax Series 229, SensorMedics, USA).  PFTs (MFVL, PImax, and PEmax) 
were measured to establish resting values.  Four minutes of baseline with participant 
sitting on the cycle ergometer were taken followed by four minutes of warm-up at 20 
watts (W).  At the end of the warm-up, incremental exercise began and the resistance of 
the cycle ergometer was increased 25W every minute until volitional fatigue.  Pedaling 
frequency was maintained at 60-70 revolutions per minute (RPM).  The end of the test 
was determined when subjects could not maintain a pedal frequency of >50 RPM for five 
consecutive pedal revolutions.  Following a four minute cool-down, post-PFTs were 
made.  VO2peak was determined by the average VO2 in the last minute of exercise.  
Arterial oxygen saturation (SaO2) was determined by a pulse oximeter (Datex-Ohmeda 
3900P, Madison, WI) which was attached and secured to the earlobe to ensure accuracy 
and minimize movement artifacts.  The workload associated with 85% of VO2peak was 
calculated which was used in sub-maximal exercise.  Workload was adjusted if during the 
VO2 practice session was <80% VO2peak or > 90% VO2peak.  
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Discontinuous Exercise Protocol 
Pulmonary function measurements and a venous blood sample were made prior to 
submaximal exercise.  Subjects then ingested NAC or PLA and rested 45 minutes in the 
lab for peak blood concentration to occur (Borgstrom, Kagedal, & Paulsen, 1986; De 
Bernardi di Valserra,M. et al., 1989; Matuszczak et al., 2005; Sen et al., 1994).  At 45 
minutes, a second blood sample was taken followed by four minutes of baseline 
metabolic data, followed by four minutes of warm-up (20W).  Subjects then cycled for 
five minutes at their predetermined 85% VO2peak workload, at which time they stopped 
pedaling for two minutes while repeat PImax and PEmax measurements and a venous blood 
sample were made.  Following this two minute rest, subjects immediately began cycling 
at the specified workload and followed this protocol for a total of six bouts of exercise 
(30 minutes total).  Post-PFTs and bloods were taken at the conclusion of a three minute 
cool-down.   
 
Continuous Protocol 
Subjects also completed two continuous exercise bouts at ~85% VO2peak.  PFT 
measurements and venous blood samples were made prior to exercise.  Participants then 
loaded with NAC or PLA and waited for an absorption period of 45 minutes.  At the 
conclusion of the 45 minutes, another blood sample was taken followed by baseline data 
collection for four minutes, and finally four minutes of warm-up at 20W.  After warm-up, 
exercise was performed at 85% VO2peak work-rate until volitional fatigue.  Pedal 
frequency was maintained at 60-70 RPM.  If a participant voluntarily stopped despite 
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verbal encouragement or pedal frequency < 50 RPM, the test was terminated.  A three 
minute cool-down was performed followed by post-PFTs and a venous blood sample. 
 
Venous Blood Sampling 
A 22gauge, in-dwelling catheter was placed in the right antecubital vein of each 
subject at the beginning of each testing session.  Samples were taken in 3cc syringes 
treated with heperanized saline, transferred to vacutainers treated with EDTA, and placed 
on ice.  After each draw, the catheter was flushed with heperanized saline to keep the line 
patent.  All samples were kept on ice before and immediately after being centrifuged.  
Resulting plasma was frozen for later determination of both plasma total glutathione 
concentration (Biovision ApoGSH Glutathione Colorimetric Detection Kit, Mountain 
View, CA) and plasma lactate concentration (YSI 2300 STAT Plus Glucose and Lactate 
Analyzer, Yellow Springs Instruments, Yellow Springs, OH). 
 
Statistics 
SigmaSTAT statistical software (Jandel Scientific Software) was used for data 
analysis.  Data is presented as mean + standard deviation.  Differences were determined 
by a 2x2 (group x time) ANOVA.  A Tukey post hoc analysis was performed to 
determine where significant differences existed.  Statistical significance was set at P< 
0.05 for all analysis.  
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CHAPTER 4 - Results 
Subject Characteristics 
Subject characteristics are shown in Table 1.  Subjects were active, but not 
competitively trained.  All subjects pulmonary function values were within normal 
predicted values.  Also, subjects stated that they maintained activity status throughout the 
study.  No known side effects of NAC were reported by the subjects. 
Table 1: Subject Characteristics 
Age (yr) 22.0 + 2.3 
Weight (kg) 77.3 + 15.7 
Height (cm) 181.0 + 11.1 
BMI (kg/m2) 23.6 + 4.2 
PEF (l/sec) 7.65 + 1.7 
FEF25-75 (l/sec) 4.48+ 1.2 
FEV1 (l/sec) 4.22 + 0.47 
FVC (l) 5.06 + 0.34 
FEV1/FVC 
(%) 
83.0 + 6.5 
TLC (l) 6.43 + 1.56 
VC (l) 4.65 + 0.68 
RV(l) 1.78 + 1.25 
 
Table 1: All values are mean + SD.  BMI: body mass index; PEF: peak expiratory flow; 
FEF25-75%: forced expiratory flow during 25-75% of vital capacity; FEV1: forced 
expiratory volume in 1 second; FVC: forced vital capacity; TLC: total lung capacity; VC: 
vital capacity; RV: residual volume. 
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VO2peak Data 
Table 2 shows data recorded at VO2peak.  At end exercise, all subjects had an 
RER>1.10, HR within 10% of maximal HR, and with minimal desaturation (>94% 
SaO2).     
Table 2: VO2peak Data 
VO2 (l/min) 3.25 + 0.42 
VO2 (ml/kg/min) 42.7 + 5.1 
VE (l/min) 118.3 + 19.4 
VE/VO2 36.9 + 5.7 
VE/VCO2 32.6 + 4.2 
RER 1.13 + 0.05 
SaO2 (%) 96.9 + 1.5 
HR (bpm) 177.1 + 9.4 
 
Table 2: All values are mean + SD.  VE: minute ventilation; RER: respiratory exchange 
ratio. 
Plasma Glutathione 
Glutathione (GSH) during submaximal exercise testing is presented in Table 3.  
There was no change (p>0.05) in GSH in each stage; i.e., pre-loading (PRE), post-loading 
(POST), minutes 5-30, or post-exercise (POST-EX); nor was there a change (p>0.05) in 
plasma GSH between groups (PLA vs. NAC). 
 
Maximum Inspiratory and Expiratory Pressure  
Mean maximal inspiratory and expiratory pressures (PImax, PEmax respectively) 
taken during submax exercise tests are shown in Table 5.  Figure 1 shows mean PImax at 
rest and each time point during exercise.  There were no differences (p>0.05) in PImax at 
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rest between groups.  During exercise, PImax was significantly lower (~14%) during 
placebo at minutes 25 and 30 compared to rest, suggesting significantly less respiratory 
muscle fatigue with NAC.  PImax did not change from rest to exercise with NAC 
supplementation.  Individual values at minute 30 are shown in Figure 2.  There was 
significantly lower PImax in PLA in 6 of 8 subjects.  There was no change (p>0.05) 
between placebo and NAC at rest or during exercise (minute 5-30) in PEmax.  Also, for the 
constant load continuous exercise trials, PImax was not different (p>0.05) prior to exercise 
(NAC: 137.5+21.7cmH2O; PLA: 129+24.3cmH2O), but was significantly lower (~16%) 
following exercise with placebo compared to NAC (PLA: 117.4+28.1cmH2O; NAC: 
135.2+23.7cmH2O).  
 Table 3: Plasma Glutathione (Discontinuous Exercise Bout) 
Rest Post-loading 5-min 10-min 15-min 20-min 25-min 30-min Post-Exercise  
PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC 
GSH 
(ng/L) 
26.7 
+ 
13.3 
22.6 
+  
4.9 
24.9 
+ 
5.4 
23.4  
+ 
6.1 
21.6  
+ 
6.5 
26.9 
+ 
9.2 
25.7 
+ 
10.0 
24.4  
+ 
7.0 
23.9 
+ 
7.9 
24.7 
+ 
6.3 
23.6 
+ 
8.8 
23.8 
+ 
8.8 
22.6 
+ 
5.1 
22.0 
+ 
4.4 
24.5 
+ 
9.8 
24.9 
+ 
7.8 
22.7  
+ 
7.6 
21.5  
+  
5.3  
Table 3: Discontinuous plasma glutathione (GSH) levels shown in placebo (PLA) and N-Acetylcysteine (NAC) conditions 
during rest, post-loading of supplementation (PLA or NAC), five minute exercise bouts, and post-exercising conditions.  GSH 
was not different between conditions or across time (p>0.05).  All values are mean + SD. 
 
Table 4: Plasma Glutathione (Continuous Exercise Bout) 
Rest Post-Loading Post-Exercise  
PLA NAC PLA NAC PLA NAC 
GSH  
(ng/L) 
24.1 + 5.5 32.8 + 23.1 23.5 + 6.1 24.0 + 9.7 28.3 + 15.6 27.4 + 14.1 
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Table 4: Plasma glutathione (GSH) levels during continuous exercise bouts are shown with placebo (PLA) and N-
Acetylcysteine (NAC) conditions during rest, post-loading of supplementation (PLA or NAC), and post-exercise.  GSH was 
not different between conditions or across time (p>0.05).  All values are mean + SD. 
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 Rest 5-minute 10-minute 15-minute 20-minute 25-minute 30-minute Post-Exercise 
PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC 
PI max 
(cmH2O) 
138.5 
+  
27.1 
140.2  
+  
31.7 
138.1  
+  
28.0 
141.3 
+  
29.7 
137.1  
+  
30.9 
140.3 
+  
29.4 
135.7 
+  
27.5 
139.1 
+ 
 26.1 
128.5 
+  
28.7 
137.9 
+ 
 25.7 
123.7 
+  
27.3 
139.7 
+ 
25.7* 
124.9 
+  
22.7 
135.9 
+ 
27.1* 
125.7  
+  
23.1 
13
 
 
 
 
 
 
 
Table 5: Mean Maximum Inspiratory and Expiratory Pressures 
6.8 
 +  
.7 24
PE max 
(cmH2O) 
154.5 
+ 
 35.2 
153.6  
+  
25.8 
153.8 
 +  
28.5 
138.4  
+  
37.0 
149.6 
 +  
29.8 
151.4 
+  
31.5 
140.1 
+  
29.1 
155.6 
+ 
 31.4 
134.3 
+  
28.9 
152.1 
+ 
 33.5 
142.4 
+  
28.6 
150.3 
+ 
 34.0 
139.0 
+  
32.2 
149.6 
+  
30.3 
141.7 
 +  
39.5 
140.9 
 + 
1  29.
 
Table 5: Inspiratory and Expiratory pressures, taken at rest, each five-minute exercise bout, and post-exercise.  All values are 
mean + SD, * = p< 0.05 
 
 
 
 
 Figure 1: Maximum Inspiratory Pressure versus Time 
 
Figure 1: Maximal inspiratory pressures with placebo (PLA) showed a significant 
decrease at minute 25 and 30 of constant load exercise (~85% VO2peak) compared to 
resting conditions.  N-Acetylcysteine (NAC) trials show no difference (p>0.05) from rest 
throughout exercise.  Therefore, PImax was significantly lower with PLA at minutes 25 
and 30 versus NAC. 
 
Figure 2: Individual and Mean Inspiratory Pressures at minute 30 
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 Figure 2: An increase in maximal inspiratory pressures was observed in 6 of 8 subjects 
with N-Acetylcysteine (NAC) with a mean increase of ~8%; *p<0.05. 
Exercise Response 
Exercise VO2 (percent of VO2peak) averaged 79.5 + 4.9% at minute 5, 84.8 + 4.1% 
at minute 10, 88.4 + 8.1% at minute 15, 87.4 + 10.9% at minute 20, 87.9 + 7.6% at 
minute 25, and 86.6 + 9.9% at minute 30.  Table 6 shows metabolic data during the 
discontinuous exercise test.  Figure 3 shows VO2 versus time, Figure 4 shows heart rate 
versus time, and Figure 5 shows ventilation versus time.  There was no significant 
difference between PLA and NAC in any measured variable throughout exercise.  
Individual and mean time to exhaustion (Tlim), during the continuous exercise bout at 
85% VO2peak, is presented in Figure 6.  Although there was no significant difference 
between PLA and NAC (1263 + 334 sec PLA; 1047 + 136 sec NAC), time to exhaustion 
was less in 6 of 8 subjects during NAC trials. 
 
Figure 3: VO2 versus Time 
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Figure 3: Whole body oxygen uptake (VO2) versus time (in five-minute bouts) in both 
PLA (placebo) and NAC (N-Acetylcysteine).  There were no differences between PLA or 
NAC (p>0.05). 
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Rest 5-minute 10-minute 15-minute 20-minute 25-minute 30-minute  
PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC PLA NAC 
VO2 (l/min) 0.27 + 
0.05 
0.30 + 
0.09 
2.58 + 
0.37 
2.60 + 
0.40 
2.75 + 
0.30 
2.78 + 
0.31 
2.80 + 
0.31 
2.74 + 
0.34 
2.80 + 
0.37 
2.83 + 
0.43 
2.85 + 
0.44 
2.84 + 
0.46 
2.81 + 
0.47 
2.86+ 
0.44 
VO2 
(ml/kg/min) 
3.6 + 0.6 3.9 + 0.9 34.0 + 
5.3 
34.0 + 
4.5 
36.2 + 
4.3 
36.6 + 
4.8 
36.9 + 
4.9 
36.0 + 
3.9 
36.9 + 
5.2 
37.2 + 
5.3 
37.5 + 
5.7 
37.1 + 
4.7 
37.0 + 
6.2 
37.1 + 
5.9 
VE (l/min) 11.7 + 
2.4 
13.0 + 
3.7 
63.1 + 
23.8 
77.6 + 
15.6 
80.7 + 
12.7 
85.2 + 
18.0 
88.5 + 
16.9 
91.5 + 
19.6 
93.2 + 
21.7 
96.8 + 
24.0 
94.9 + 
19.7 
96.0 + 
22.2 
98.4 + 
23.8 
96.2 + 
25.2 
VE/VO2 58.9 + 
28.1 
60.9 + 
22.9 
28.4 + 
2.8 
29.9 + 
4.0 
29.3 + 
2.7 
30.4 + 
4.2 
31.6 + 
5.2 
33.3 + 
5.6 
33.1 + 
6.0 
34.1 + 
5.5 
33.3 + 
6.1 
33.6 + 
4.9 
35.0 + 
6.8 
33.4 + 
4.9 
VE/VCO2 69.3 + 
26.0 
67.5 + 
21.8 
27.8 + 
2.2 
29.6 + 
3.2 
30.6 + 
2.4 
31.6 + 
3.6 
32.9 + 
4.0 
34.6 + 
5.0 
34.8 + 
5.3 
35.4 + 
4.5 
34.9 + 
5.3 
35.5 + 
4.8 
36.6 + 
5.6 
35.7 + 
4.0 
RER 0.82 + 
0.06 
0.86 + 
0.7 
1.02 + 
0.04 
1.02 + 
0.03 
0.96 + 
0.02 
0.97 + 
0.03 
0.96 + 
0.04 
0.97 + 
0.3 
0.96 + 
0.04 
0.96 + 
0.02 
0.96 + 
0.03 
0.95 + 
0.02 
0.95 + 
0.4 
0.94 + 
0.03 
SaO2 (%) 98.0 + 
0.8 
98.5 + 
0.9 
97.0 + 
2.0 
96.8 + 
1.8 
96.5 + 
1.9 
96.8 + 
1.8 
96.6 + 
2.4 
96.5 + 
2.5 
95.6 + 
4.4 
95.8 + 
2.9 
96.4 + 
2.4 
95.9 + 
1.9 
95.9 + 
3.2 
96.0 + 
2.6 
HR (bpm) 64.9 + 
11.1 
65.3 + 
6.8 
145.4 + 
10.8 
140.9 + 
22.1 
151.3 + 
23.1 
148.9 + 
21.7 
158.4 + 
17.4 
153.3 + 
30.1 
155.3 + 
32.6 
166.8 + 
11.8 
160.4 + 
27.5 
164.9 + 
14.9 
165.3 + 
14.9 
162.9 
+ 15.3 
RPE 
Borg (1-10) 
----- ----- 3.3 + 
1.9 
3.4 + 
0.9 
4.1 + 
1.8 
4.7 + 
1.4 
5.3 + 
1.4 
6.3 + 
1.6 
6.3 + 
1.4 
7.4 + 
1.6 
7.9 + 
1.6 
8.1 + 
1.0 
8.6 + 
2.1 
8.6 + 
1.1 
RPD 
Borg (1-10) 
----- ----- 3.3 + 
1.9 
2.3 + 
0.5 
3.7 + 
1.6 
4.0 + 
0.9 
4.6 + 
1.7 
5.7 + 
2.3 
5.7 + 
1.6 
6.4 + 
2.2 
6.7 + 
1.9 
6.3 + 
1.5 
8.0 + 
2.4 
7.2 + 
1.9 
Lactate 
(mM) 
1.92 + 
0.74 
2.14 + 
1.03 
5.50 + 
1.59 
5.36 + 
1.03 
8.35 + 
1.30 
8.40 + 
1.57 
10.23 + 
1.61 
9.31 + 
1.24 
9.79 + 
1.76 
9.79 + 
1.45 
9.26 + 
3.21 
9.63 + 
1.84 
10.76 + 
2.57 
9.75 + 
1.94 
  
Table 6: Metabolic indices during discontinuous exercise bouts in both placebo (PLA) and N-Acetylcysteine (NAC).  All 
values are mean + SD.  There were no differences (p>0.05) in any measured variable across time.  RPE: rating of perceived 
exertion; RPD: rating of perceived dyspnea. 
Table 6: Submaximal Discontinuous Exercise 
 
 
 
 Figure 4: HR versus Time 
 
Figure 4: Heart rate versus time in placebo (PLA) and N-Acetylcysteine (NAC).  No 
differences between PLA and NAC (p>0.05) were observed. 
 
Figure 5: Ventilation (VE) versus Time 
 
Figure 5: Minute ventilation (VE) in placebo (PLA) and N-Acetylcysteine (NAC).  No 
differences between PLA and NAC were detected (p>0.05). 
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 Figure 6: Time to Exhaustion (Tlim) 
 
Figure 6: Individual and mean time to exhaustion (Tlim) during continuous exercise bout 
comparing placebo (PLA) and N-Acetylcysteine (NAC) conditions.  No difference 
between PLA and NAC was found (p>0.05). 
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 CHAPTER 5 - Discussion 
Major Findings 
The purpose of this study was to determine the effect of an acute, oral dose of N-
Acetylcysteine on respiratory muscle fatigue during heavy exercise.  Our major original 
findings support our hypothesis that an acute oral dose of N-Actylcysteine (NAC) 
reduces respiratory muscle fatigue during heavy intermittent exercise in healthy humans.  
Our results also demonstrated that NAC supplementation did not alter any of our 
measured ventilatory or metabolic measurements during exercise, nor was time to 
exhaustion changed compared to placebo.  These results support the belief that oxidative 
stress contributes to respiratory muscle fatigue during heavy exercise.    
 
Respiratory Muscle Fatigue 
Our findings that NAC reduced respiratory muscle fatigue during heavy exercise 
are in agreement with several previous studies using both animal and human models.  
However, the vast majority of studies have infused NAC rather than administered NAC 
orally.  Specifically, it has been shown that intravenous loading of NAC, 0.75ml/kg of a 
200mg/ml NAC solution over a time period of five minutes, exhibited higher esophageal 
pressure and volume generation during loaded inspiratory pressures in rats (Supinski et 
al., 1997b).  Also in the rat model, under tetanic stimulation, bundles of diaphragm strips 
incubated in 10mM of NAC dissolved in Krebs-Ringer solution showed a 1.8-fold higher 
force development (Mishima et al., 2005).  Collectively, the reports demonstrate that 
intravenous loading of NAC can decrease fatigue and increase force development in the 
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 respiratory muscles of the rat.  Similar effects have been shown in humans.  Travaline et 
al. (1997) demonstrated an increase in task endurance, determined by the sum of four 
diaphragmatic fatigue times during resistive breathing maintained at 80% targeted 
diaphragmatic twitch pressure, by NAC infusion (150 mg/kg in 250 ml of D5W) during 
inspiratory resistive loading in healthy human subjects.  Although this study used 
electrophrenic twitch stimulation and transdiaphragmatic twitch occlusion to establish 
diaphragmatic fatigue (see Travaline et al. 1997 for protocol detail), which was induced 
by loaded inspiratory breathing, and NAC infusion, the results are similar to our study in 
that NAC was able to improve diaphragm strength and reduce fatigue. 
There is minimal research demonstrating the effects of oral supplementation of 
NAC on muscle fatigue in humans.  The only known human oral supplementation studies 
are by Koechlin et al. (2004) who used 1800mg/day for 4 days with an additional 600mg 
on testing day in COPD patients, Sen et al. (1994b) who used 800mg/day for 2 days with 
an additional 800mg on testing day in healthy humans, and Matuszczak et al. (2005) who 
used 150mmol in 100mL of 0.9% saline in healthy humans.  However, unlike our study, 
other skeletal muscles (i.e. the quadriceps) were examined.  Koechlin et al. (2004) 
showed an improvement of 25% (208 + 23 seconds) quadriceps endurance with NAC 
supplementation, compared to our study of 14% improvement of respiratory muscles, as 
well as decreased whole body oxidative stress (measured by superoxide anion release) 
(Koechlin et al., 2004).  Sen et al. (1994b) determined the effect of NAC supplementation 
on different exercise intensities and changing levels of glutathione (GSH) and reduced 
glutathione (GSSG) in the blood.  These authors did not observe GSH or GSSG values 
changing during either aerobic or anaerobic threshold exercises.  Matusczcak et al. (2005) 
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 determined that NAC supplementation can increase force production in the forearm 
(assessed by handgrip dynamometers).  However, these studies are the only three studies 
to our knowledge to use oral dosing in humans.  Koechlin et al. (2004) associated 
improvements in quadriceps endurance with reduced oxidative stress in the body.  From 
these reports, it suggests that a decrease in oxidative stress, without a change in blood 
plasma values, while still improving muscle function, makes it possible for NAC to be 
effective in reducing respiratory muscle fatigue.  Specific mechanisms responsible for the 
reduced respiratory muscle fatigue with NAC are not known. 
Respiratory muscles fatigue can be due to both peripheral and central (stemming 
from the central nervous system) mechanisms.  Since peripheral fatigue reflects a change 
in biochemical processes directly at the muscle, the effect of increased accumulation of 
ROS may influence peripheral muscle fatigue via Type III and IV muscle afferents (see 
below) to compromise blood flow from locomotor muscles and increase respiratory 
muscle blood flow (Amann & Calbet, 2008).  Central fatigue may influence respiratory 
muscle fatigue by enhancing an inhibitory feedback on central command (Calbet et al., 
2003).  However, this may only be seen in hypoxic conditions.  During central fatigue, 
exercise induced changes in the neurotransmitter systems, mostly demonstrated by 
inadequate oxygen delivery to the capillaries and mitochondria, also influences peripheral 
fatigue (Davis & Bailey, 1997; Meeusen, Watson, Hasegawa, Roelands, & Piacentini, 
2006).  The sensory feedback, linking the fatiguing locomotor and respiratory muscles to 
the regulation of central motor drive, links peripheral and central fatigue together.  This 
inhibitory neural feedback has been suggested to be in proportion to the magnitude of 
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 peripheral locomotor fatigue and that the rate at which peripheral fatigue develops has 
dose-dependent relationship to the trigger of central fatigue (Amann & Dempsey, 2008). 
 
Significance of Respiratory Muscle Fatigue 
Reduced respiratory muscle fatigue during exercise with NAC may improve 
whole body exercise performance.  This theory is proposed by Dempsey, Romer, 
Rodman, Miller, and Smith (2006), who state that with respiratory muscle fatigue, 
exercise performance is limited via several processes.  It has been previously determined 
that up to ~14-16% of total cardiac output is shifted to the respiratory muscles during 
sustained hyperventilation and high-intensity exercise (Harms et al., 1997).  With this 
increased cardiac output directed to the respiratory muscles when respiratory muscles are 
likely fatiguing, there is an activated respiratory muscle metaboreflex which increases 
sympathetic outflow and locomotor muscle vasoconstriction (decreased cardiac output to 
the locomotor muscles) (Dempsey et al., 2006; Harms et al., 1997).  It has been 
hypothesized that reducing respiratory muscle fatigue will improve exercise performance 
by attenuating a muscle metaboreflex in central command causing Type III and IV 
muscle afferents to de-activate the blood flow steal phenomena (Dempsey et al., 2006; 
Harms et al., 1997; Harms et al., 1998) directing respiratory muscle cardiac output to the 
skeletal muscles.  Also, if respiratory muscle fatigue is cause for locomotor muscle 
fatigue (Dempsey et al., 2006), and if respiratory muscle fatigue can be decreased and/or 
prevented, as in the present study, time to exhaustion during whole body exercise may 
theoretically increase.  
 35
 In the present study, respiratory muscle fatigue was reduced with NAC 
supplementation, but time to exhaustion was not changed.  However, our protocol was 
not specifically designed to test this performance question.  Multiple exercise sessions are 
necessary to reduce intra-test variability to accurately assess performance issues.  Our 
study, however, is in agreement with a recent study by Medved et al. (2003) who found 
that intravenous loading of NAC did not increase exercise performance during high-
intensity intermittent cycling.  The effect on respiratory muscles is unknown; however, 
these authors suggest NAC may have an effect on low-frequency fatigue protocols, but 
not high-intensity exercise (Medved et al., 2003).   
Although we did not see an increase in time to exhaustion, several studies have 
found NAC increases endurance performance.  With human subjects, time to fatigue 
increased by ~23% during submaximal (90%VO2max) cycling exercise (McKenna et al., 
2006) with intravenous loading (125mg/kg/hr for 15 minutes and 25mg/kg/hr for duration 
of exercise) of NAC.  During electrical stimulation of the tibialis anterior, NAC increased 
time to fatigue during low-frequency, but not high-frequency stimulation.  This is in 
agreement with Medved et al. (2003), who suggest that high-intensity exercise may not 
be affected by NAC.  In consensus, time to exhaustion is most likely influenced by the 
type of exercise and its intensity, high versus low, when supplementing with NAC.  
However, if NAC affects endurance performance in low-frequency fatigue, it is therefore 
not feasible to use a protocol in which respiratory muscle fatigue is shown since 
respiratory muscle fatigue only occurs during high-intensity exercise (Babcock et al., 
2002; McKenna et al., 2006).  Therefore, we would likely not see exercise at lower 
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 intensities affected by NAC supplementation due to a decrease in respiratory muscle 
fatigue. 
 
Plasma Glutathione 
Plasma glutathione (GSH) did not change with oral supplementation of NAC in 
our study, which is in agreement with others (Gohil, Viguie, Stanley, Brooks, & Packer, 
1988; Medved et al., 2003).  The purpose of testing GSH was to identify an increase in 
GSH due to supplemented NAC (pre- to post-supplementation of NAC) and not GSH’s 
effect during exercise.  Increases are typically observed in whole blood GSH, not plasma.  
Although the following studies tested whole blood and plasma GSH during exercise, it is 
possible to understand why the current study did not detect any plasma GSH differences.  
Medved et al. (2003) determined that whole blood GSH decreased and whole blood 
GSSG increased with intense intermittent cycling, but, as stated previously, they were 
unable to detect plasma GSH status.  In another study, NAC increased red blood cell 
GSH during hand grip exercise (50% maximal voluntary contraction, 3 seconds on, 3 
seconds off) (Matuszczak et al., 2005).  To ensure NAC was responsible for these 
increases in total blood GSH, Medved et al. (2004a) measured total NAC, whole blood 
NAC, and whole blood GSH pre- and post-submax cycling exercise.  Significant changes 
were found in total NAC, whole blood NAC, and whole blood GSH suggesting NAC is 
responsible for the increase in whole blood GSH (Medved et al., 2004a).  To accurately 
account for NAC supplementation in the body, it may perhaps be best to use whole blood 
assays versus plasma only assays.  
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 Metabolic and Ventilatory Indices 
During NAC supplementation, whole body VO2, HR, VE, or lactate did not differ 
when compared to placebo trials.  To date, reports on the effect of NAC on these 
measures during sustained heavy exercise has yet to be determined.  Reid et al. (1994) 
and Travaline et al. (1997) did report no significant differences between heart rate and 
blood pressure with NAC infusion during low (10 Hz) and high (20 Hz) frequency 
stimulation in the tibialis anterior and resistive breathing at ~80% inspiratory pressure 
using diaphragmatic twitch occlusion, respectively.  Therefore, it would be important to 
assess changes in these variables in future studies to possibly establish a connection 
between reduced respiratory muscle fatigue with NAC and improved exercise 
performance.  
 
Limitations 
There are several potential limitations which may have influenced our results.  
First, it is not possible to measure respiratory muscle fatigue directly in human subjects.  
Historically, bilateral phrenic nerve stimulation (BPNS) is the gold standard for assessing 
diaphragmatic fatigue.  However, measuring respiratory muscle pressure at the mouth, as 
was performed in our study, has been shown to elicit similar effects as BPNS and been 
used in many previous studies (Huang et al., 2003; Inbar et al., 2000; Romer, McConnell, 
& Jones, 2002a; Romer, McConnell, & Jones, 2002b; Sonetti et al., 2001).  Since PImax 
maneuvers are effort-dependent, subjects in our study were highly encouraged to perform 
maximal effort, tests were made in triplicate, and lung volume measures were made with 
each trial to ensure consistency.  Although pressures taken at the mouth tend to have a 
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 learning effect, it has been shown that keeping the number of trials to 3 or fewer with a 
warm-up session decreases the learning effect and allows for less subject variability 
(Volianitis, McConnell, & Jones, 2001) and does not contribute itself to respiratory 
muscle fatigue.   
Determining exercise performance was not the primary goal of this study.  
However, our subjects did perform a continuous single volitional exercise test at 85% 
VO2peak while under placebo and NAC conditions.  However, we realize that this is not 
sufficient evidence to address performance questions.  To determine the effects of NAC 
on time to exhaustion, multiple exercise sessions should be analyzed during both placebo 
and NAC trials to reduce subject and test variability.  Also, our measurements did not 
take into account any mechanistic significance for respiratory muscle fatigue.  For 
example, leg blood flow was not measured so we do not know if a cardiac output shift 
from the locomotor muscles to the respiratory muscles occurred during PLA trials, nor do 
we know if the blood flow shift during the NAC trials failed to occur because of the 
reduction in respiratory muscle fatigue.   
Whole blood GSH measurements appear to be more effective than plasma GSH 
(Medved et al., 2003; Medved et al., 2004a).  These authors explain that whole blood 
GSH measurements may be more responsive than plasma GSH measurements.  The 
current study did not show an increase in plasma GSH, therefore, we may have seen an 
increase following NAC supplementation if we measured whole blood GSH.  
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 Future Directions 
Future research is worthwhile to expand our understanding of NAC’s effect on 
respiratory muscle fatigue and exercise performance.  First, it would be interesting to 
determine NAC’s influence on exercise performance.  Does reduced respiratory muscle 
fatigue with NAC lead to an increase in exercise performance?  If so, under what exercise 
conditions or subject population?  Also, if respiratory muscle fatigue is alleviated, is there 
a reverse direction of blood flow shift from the respiratory muscles to the exercising 
locomotor muscles, or perhaps less of a “steal”?  Furthermore, experimenting with 
greater or lesser doses of NAC would be of interest to see if similar effects occur; i.e. do 
higher doses of oral NAC elicit greater amounts of fatigue alleviation, or will a chronic 
dose be more beneficial than an acute oral dose?  Finally, subject selection is important in 
future research.  Our subjects were healthy active males.  Would we see similar effects 
with women, older adults, or diseased populations, such as COPD?  Is work of breathing 
reduced because of NAC’s effect on decreasing oxidative stress and decreased respiratory 
muscle fatigue?  Will different populations receive greater benefits from NAC’s effect on 
reducing oxidative stress due to aging and disease effects on the cardiopulmonary 
system?  Our results obviously lead to many worthwhile future studies on the effect of 
NAC on both respiratory muscles and exercise performance. 
 
Summary 
In conclusion, this study has confirmed recent evidence that oxidative stress 
contributes to respiratory muscle fatigue by showing that an acute oral dose of NAC will 
reduce respiratory muscle fatigue during heavy exercise.  We believe this is important 
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 because respiratory muscle work and respiratory muscle fatigue has been attributed to 
limiting exercise performance in healthy subjects during heavy exercise.  To date, NAC 
supplementation during exercise has had contradictory results regarding time to fatigue 
during high versus low intensity exercise and loading conditions (chronic versus acute, 
oral versus intravenous).  Also, specific mechanisms responsible for reduced respiratory 
muscle fatigue with NAC are not yet known.  Future research is obviously needed and 
warranted to gain a greater understanding of factors contributing to respiratory muscle 
fatigue during exercise.   
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